FGFBP1通过KLK10-AKT轴促进三阴性乳腺癌的进展
Ziqi Wang1, Ruoqing Hou1, Shiyu Wang1
1Department of Ultrasonography, Fudan University Shanghai Cancer Center, Xuhui District, Shanghai, 200032, China; Department of Oncology, Shanghai Medical College, Fudan University, Xuhui District, Shanghai, 200032, China.
纤维细胞生长因子结合蛋白1 (FGFBP1) 促进三阴性乳腺癌 (TNBC) 的生长和扩散. 向FGFBP1可能通过抑制KLK10-AKT通路为TNBC提供新的治疗策略.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
背景情况:
- 三阴性乳腺癌 (TNBC) 是具有攻击性且缺乏向治疗的.
- 纤维细胞生长因子 (FGF) 途径与TNBC进展有关.
- FGFBP1释放FGFs,但其在TNBC中的作用尚不清楚.
研究的目的:
- 调查FGFBP1在TNBC进展中的作用.
- 阐明FGFBP1影响TNBC的分子机制.
主要方法:
- 在体外和体内实验中使用TNBC细胞系进行实验.
- 对FGFBP1,KLK10和AKT通路表达的分析.
- 基因淘汰和途径抑制研究.
主要成果:
- 过度表达FGFBP1增强了TNBC细胞的增殖,迁移和入侵.
- FGFBP1对KLK10进行了上调,激活了AKT通路.
- 击败FGFBP1或KLK10,或抑制AKT,可以逆转这些效应.
结论:
- FGFBP1通过KLK10-AKT轴促进TNBC的进展.
- 向FGFBP1代表了TNBC的一个潜在的治疗策略.
更多相关视频
06:51Utilizing 18F-FDG PET/CT Imaging and Quantitative Histology to Measure Dynamic Changes in the Glucose Metabolism in Mouse Models of Lung Cancer
Published on: July 21, 2018
06:52Monitoring Breast Cancer Growth and Metastatic Colony Formation in Mice using Bioluminescence
Published on: November 5, 2021
相关概念视频
PI3K/mTOR/AKT Signaling Pathway
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
Tumor Progression
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Mitogens and the Cell Cycle
Interactions Between Signaling Pathways
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Negative Regulator Molecules
